Inventor
CASU BENITO
IT21 patents
⚠️ This page may combine multiple inventors who share the name “CASU BENITO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CRINOS INDUSTRIA FARMACO
5 patentsUS5008253AApr 16, 1991
Sulfoamino derivatives of chondroitin sulfates of dermatan sulfate and of hyaluronic acid and their pharmacological properties
CRINOS INDUSTRIA FARMACO53 citations94
US5605891AFeb 25, 1997
Use of polysaccharides in acute peripheral neuropathies
CRINOS INDUSTRIA FARMACO20 citations91
US4369256AJan 18, 1983
Polyalkylene resins crosslinked with diisocyanate used for selective separation of heparin from other glucosaminoglycanes
CRINOS INDUSTRIA FARMACO14 citations73
US5152998AOct 6, 1992
Process for the isolation and purification of monosialoganglioside from a starting lipidic mixture by complexation with alpha-cyclodextrin and related intermediate compound
CRINOS INDUSTRIA FARMACO1 citations51
US5108613AApr 28, 1992
Process for the isolation and purification of monosialoganglioside from a starting lipidic mixture by complexation with alfa-cyclodextrin and related intermediate compound
CRINOS INDUSTRIA FARMACO1 citations51
MASSACHUSETTS INST TECHNOLOGY
3 patentsUS7508206B2Mar 24, 2009
Method for sequence determination using NMR
MASSACHUSETTS INST TECHNOLOGY33 citations95
US7737692B2Jun 15, 2010
Method for sequence determination using NMR
MASSACHUSETTS INST TECHNOLOGY5 citations73
US7728589B2Jun 1, 2010
Method for sequence determination using NMR
MASSACHUSETTS INST TECHNOLOGY5 citations73
CASU BENITO
2 patentsUS8067555B2Nov 29, 2011
Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
CASU BENITO16 citations90
US8222231B2Jul 17, 2012
Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
CASU BENITO3 citations60